Paul A. Marks, MD
Scientific Advisory Board

Dr. Marks has published over 350 scientific articles in various scholarly journals. Dr. Marks is a member of the National Academy of Sciences and the Institute of Medicine. He is a Fellow of the America Academy of Arts and Sciences. He has been the recipient of a number of honors including the Distinguished Achievement Medal of Columbia University; Medal of the Japan Foundation for the Promotion of Cancer Research; Centenary Medal of the Pasteur Institute, honorary degrees from several universities and the President's National Medal of Science (USA). In addition to his many scientific and academic accomplishments, Dr. Marks is one of the founders of Aton Pharma, a biopharmaceuticals company started in 2001 to develop and commercialize novel therapeutics for cancer and other diseases. The company was acquired by Merck & Co., Inc. in 2004.

(Editor's Note: This profile is substantially reproduced from http://www.carrotcapitalhealthcareventures.com/fund1.html).